{"id":"https://openalex.org/W2004470488","doi":"https://doi.org/10.1016/s0006-3223(96)00224-7","title":"Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects","display_name":"Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects","alternate_titles":[],"publication_year":1997,"publication_date":"1997-05-01","ids":{"openalex":"https://openalex.org/W2004470488","doi":"https://doi.org/10.1016/s0006-3223(96)00224-7","mag":"2004470488","pmid":"https://pubmed.ncbi.nlm.nih.gov/9110100"},"language":"en","primary_location":{"id":"doi:10.1016/s0006-3223(96)00224-7","doi":"https://doi.org/10.1016/s0006-3223(96)00224-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0006-3223(96)00224-7","pdf_url":null,"source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004470488"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s0006-3223(96)00224-7","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014384359","display_name":"Linda C. Barr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Linda C. Barr","raw_affiliation_strings":["Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, USA","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039312313","display_name":"George R. Heninger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George R. Heninger","raw_affiliation_strings":["Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014105109","display_name":"Wayne K. Goodman","orcid":"https://orcid.org/0000-0001-6717-082X","observed_orcids":["https://orcid.org/0000-0001-6717-082X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wayne Goodman","raw_affiliation_strings":["Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112155944","display_name":"Charney Ds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dennis S. Charney","raw_affiliation_strings":["Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031601763","display_name":"Lawrence H. Price","orcid":"https://orcid.org/0000-0002-2074-4520","observed_orcids":["https://orcid.org/0000-0002-2074-4520"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence H. Price","raw_affiliation_strings":["Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5014384359"],"corresponding_institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"],"apc_list":{"value":5489,"currency":"USD","value_usd":5489},"apc_paid":{"value":5489,"currency":"USD","value_usd":5489},"fwci":2.3613,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.84536082,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"41","issue":"9","first_page":"949","last_page":"954"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.06030000001192093,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0203000009059906,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tryptophan-depletion","display_name":"tryptophan depletion","score":0.996999979019165},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/vulnerability-to-depression","display_name":"depression vulnerability","score":0.5410000085830688},{"id":"https://openalex.org/keywords/depression-relapse","display_name":"depression relapse","score":0.7929999828338623},{"id":"https://openalex.org/keywords/mood","display_name":"mood","score":0.5659999847412109},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7879999876022339},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7739999890327454},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.8510000109672546}],"concepts":[{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.9230978488922119},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.7680848836898804},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.7531114816665649},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.7052779793739319},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.6112029552459717},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5368044972419739},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.473730206489563},{"id":"https://openalex.org/C2778630814","wikidata":"https://www.wikidata.org/wiki/Q410954","display_name":"Monoamine oxidase inhibitor","level":4,"score":0.4660542905330658},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.46147510409355164},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45235589146614075},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.4474685490131378},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4444119334220886},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.4123607575893402},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3347599506378174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3252061605453491},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11345404386520386},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.04941675066947937},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000339","descriptor_name":"Affect","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000339","descriptor_name":"Affect","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014364","descriptor_name":"Tryptophan","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0006-3223(96)00224-7","doi":"https://doi.org/10.1016/s0006-3223(96)00224-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0006-3223(96)00224-7","pdf_url":null,"source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},{"id":"pmid:9110100","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9110100","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1016/s0006-3223(96)00224-7","doi":"https://doi.org/10.1016/s0006-3223(96)00224-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0006-3223(96)00224-7","pdf_url":null,"source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3674930279","display_name":"MONOAMINE RECEPTOR SENSITIVITY AND ANTIDEPRESSANT DRUGS","funder_award_id":"R01MH036229","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G744663869","display_name":null,"funder_award_id":"MH30929","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G9000921491","display_name":"Research Training - Biological Sciences","funder_award_id":"T32MH014276","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W34384985","https://openalex.org/W1038071195","https://openalex.org/W1813557872","https://openalex.org/W1966460145","https://openalex.org/W1978341871","https://openalex.org/W1993993476","https://openalex.org/W1997326317","https://openalex.org/W2002361387","https://openalex.org/W2020523871","https://openalex.org/W2034460244","https://openalex.org/W2038315038","https://openalex.org/W2043567599","https://openalex.org/W2054149718","https://openalex.org/W2067495470","https://openalex.org/W2071359470","https://openalex.org/W2078463027","https://openalex.org/W2089452749","https://openalex.org/W2096202904","https://openalex.org/W2110080591","https://openalex.org/W2114613490","https://openalex.org/W2121892040","https://openalex.org/W2127017530","https://openalex.org/W2148412563","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2130196047","https://openalex.org/W2104103639","https://openalex.org/W2089452749","https://openalex.org/W2094488282","https://openalex.org/W2137528165","https://openalex.org/W1988245026","https://openalex.org/W2096202904","https://openalex.org/W1438123612","https://openalex.org/W2043550159"],"abstract_inverted_index":{"Short-term":[0],"reduction":[1],"in":[2,13,34,39,124,130,155],"plasma":[3],"tryptophan":[4,70,85,106,150],"(tryptophan":[5],"depletion)":[6],"produces":[7],"a":[8,47,110],"relapse":[9],"of":[10,15,66,92,105,112,128,149],"depressive":[11,32,67,147],"symptoms":[12,33,43,68],"60%":[14],"previously":[16],"depressed":[17,36,40,159],"patients":[18,37,41],"recently":[19],"recovered":[20],"with":[21,46,94,122],"serotonin":[22,55,138,156],"reuptake":[23,49,56,139,157],"inhibitor":[24,57,140],"treatment.":[25,114],"Tryptophan":[26],"depletion":[27,86,107,151],"does":[28,143],"not":[29,120,144],"consistently":[30],"increase":[31],"unmedicated":[35],"or":[38,126],"whose":[42],"are":[44,153],"remitted":[45],"norepinephrine":[48],"inhibitor.":[50],"These":[51,134],"data":[52,135],"suggest":[53],"that":[54,137,152],"treatment":[58,93,117,141],"itself":[59,118],"may":[60],"confer":[61],"vulnerability":[62,100],"to":[63,74,101],"the":[64,102,146],"development":[65],"during":[69],"depletion.":[71],"In":[72],"order":[73],"further":[75],"investigate":[76],"this":[77],"possibility,":[78],"six":[79,90],"healthy":[80,132],"individuals":[81],"underwent":[82],"double-blind":[83],"placebo-controlled":[84],"before":[87],"and":[88,160],"following":[89],"weeks":[91],"fluoxetine":[95,113,116],"20":[96],"mg/day.":[97],"No":[98],"increased":[99],"mood-lowering":[103],"effects":[104,148],"occurred":[108],"as":[109],"result":[111],"Additionally,":[115],"was":[119],"associated":[121],"changes":[123],"mood":[125],"quality":[127],"life":[129],"these":[131],"volunteers.":[133],"indicate":[136],"alone":[142],"produce":[145],"observed":[154],"inhibitor-treated":[158],"obsessive":[161],"compulsive":[162],"disorder":[163],"patients.":[164]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004470488","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
